Literature DB >> 18524525

Improved elimination of phase effects from background field inhomogeneities for susceptibility weighted imaging at high magnetic field strengths.

Alexander Rauscher1, Markus Barth, Karl-Heinz Herrmann, Stephan Witoszynskyj, Andreas Deistung, Jüergen R Reichenbach.   

Abstract

To enhance susceptibility-related contrast of magnetic resonance images, the phase of susceptibility weighted data needs to be corrected for background inhomogeneities and phase wraps caused by them. Current methods either use homodyne filtering or a combination of phase unwrapping and high pass filtering. The drawback of homodyne filtering is incomplete elimination of phase wraps in areas with steep phase topography produced by background inhomogeneities of the static magnetic field. The disadvantage of phase unwrapping is that it requires subsequent high pass filtering, which introduces artifacts in areas with very steep transitions, such as areas near interfaces between parenchyma and bone or air. A method is proposed that reduces the artifacts associated with high pass filtering without sacrificing the advantages of phase unwrapping. This technique is demonstrated with phantom data at 1.5 T and with human data at 1.5, 3 and 7 T.

Entities:  

Mesh:

Year:  2008        PMID: 18524525     DOI: 10.1016/j.mri.2008.01.029

Source DB:  PubMed          Journal:  Magn Reson Imaging        ISSN: 0730-725X            Impact factor:   2.546


  10 in total

1.  Improving contrast to noise ratio of resonance frequency contrast images (phase images) using balanced steady-state free precession.

Authors:  Jongho Lee; Masaki Fukunaga; Jeff H Duyn
Journal:  Neuroimage       Date:  2010-10-30       Impact factor: 6.556

2.  Quantitative magnetic susceptibility mapping without phase unwrapping using WASSR.

Authors:  Issel Anne L Lim; Xu Li; Craig K Jones; Jonathan A D Farrell; Deepti S Vikram; Peter C M van Zijl
Journal:  Neuroimage       Date:  2013-10-08       Impact factor: 6.556

3.  Evaluation of traumatic subarachnoid hemorrhage using susceptibility-weighted imaging.

Authors:  Z Wu; Shaowu Li; J Lei; D An; E M Haacke
Journal:  AJNR Am J Neuroradiol       Date:  2010-02-25       Impact factor: 3.825

4.  Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data.

Authors:  Karin Shmueli; Jacco A de Zwart; Peter van Gelderen; Tie-Qiang Li; Stephen J Dodd; Jeff H Duyn
Journal:  Magn Reson Med       Date:  2009-12       Impact factor: 4.668

5.  Removing background phase variations in susceptibility-weighted imaging using a fast, forward-field calculation.

Authors:  Jaladhar Neelavalli; Yu-Chung N Cheng; Jing Jiang; E Mark Haacke
Journal:  J Magn Reson Imaging       Date:  2009-04       Impact factor: 4.813

6.  Coil combination using linear deconvolution in k-space for phase imaging.

Authors:  Qian Zheng; Lin Xu; Liang Xiong; Xiao Cui; Jiaofen Nan; Taigang He
Journal:  Quant Imaging Med Surg       Date:  2019-11

7.  Post Mortem Validation of MRI-Identified Veins on the Surface of the Cerebral Cortex as Potential Landmarks for Neurosurgery.

Authors:  Günther Grabner; Thomas Haider; Mark Glassner; Alexander Rauscher; Hannes Traxler; Siegfried Trattnig; Simon D Robinson
Journal:  Front Neurosci       Date:  2017-06-21       Impact factor: 4.677

8.  Outcome from Complicated versus Uncomplicated Mild Traumatic Brain Injury.

Authors:  Grant L Iverson; Rael T Lange; Minna Wäljas; Suvi Liimatainen; Prasun Dastidar; Kaisa M Hartikainen; Seppo Soimakallio; Juha Ohman
Journal:  Rehabil Res Pract       Date:  2012-04-19

9.  Susceptibility-Weighted Imaging of the Anatomic Variation of Thalamostriate Vein and Its Tributaries.

Authors:  Xiao-fen Zhang; Jian-ce Li; Xin-dong Wen; Chuan-gen Ren; Ming Cai; Cheng-chun Chen
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

10.  Background-suppressed MR venography of the brain using magnitude data: a high-pass filtering approach.

Authors:  Zhaoyang Jin; Ling Xia; Minming Zhang; Yiping P Du
Journal:  Comput Math Methods Med       Date:  2014-06-10       Impact factor: 2.238

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.